id todo:paper_0012186X_v18_n5_p385_Tesone
record_format dspace
spelling todo:paper_0012186X_v18_n5_p385_Tesone2023-10-03T14:10:18Z Androgen receptors in the diabetic rat Tesone, M. Oliveira-Filho, R.M. Biella de Souza Valle, L. Calvo, J.C. Barañao, J.L.S. Foglia, V.G. Charreau, E.H. Androgen receptors cytosol binding sites R1881 rat prostate streptozotocin-diabetes androgen receptor androstanolone androstanolone h 3 drug receptor insulin methyltrienolone h 3 metribolone radioisotope streptozocin testosterone unclassified drug animal experiment article diabetes mellitus endocrine system male genital system prostate rat Animals Body Weight Cytosol Diabetes Mellitus, Experimental Epididymis Estrenes Insulin, Long-Acting Male Metribolone Organ Size Prostate Rats Receptors, Androgen Receptors, Steroid Testis Testosterone Testosterone Congeners Male rats rendered diabetic by IV streptozotocin (65mg/kg body weight) were treated with exogenous insulin or testosterone. Charcoal-coated dextran and polyacrylemide gel electrophoresis techniques were employed in studying the characteristics of androgen (R1881) binding to prostate cytosol protein. In comparison with normal (N) rats, the replacement therapy of diabetic (D) animals with insulin (D+I) or testosterone (D+T) was able to restore epididymal weight (N = 0.40 ±0.04 g; D = 0.18 ± 0.02 g; D+I = 0.42 ± 0.05 g; D+T = 0.40 ± 0.06 g) and total prostate weight (N = 0.24 ± 0.02 g; D = 0.15 ± 0.02 g; D+I = 0.24 ± 0.05 g; D+T = 0.35 ± 0.06 g). Testicular endogenous content of testosterone was restored after insulin treatment (N = 154 ± 13 ng/testis; D = 41 ± 5 ng/testis; D+I = 142 ± 9 ng/testis), and significant improvements of serum testosterone levels were also achieved (N = 540 ± 64 ng/100 ml; D = 238 ± 37 ng/100 ml; D+I = 358 ± 18 ng/100 ml). Prostate cytosol of streptozotocin-diabetic rats had strongly lowered capacity for 3H-R1881 binding compared with controls (94 and 12 fmol/mg protein, respectively). Testosterone treatment produced a 3.3-fold improvement of this lowered value, whereas the increment seen with insulin was less (1.5-fold). It is emphasized that some of the improvements caused by insulin replacement therapy in diabetic animals are due to the partial restoration of testosterone secretion. Thus, the combined actions of insulin and testosterone (instead of insulin alone) seem to be of major importance in the maintenance and regulation of accessory sex glands function. © 1980 Springer-Verlag. Fil:Tesone, M. Universidad de Buenos Aires. Facultad de Ciencias Exactas y Naturales; Argentina. Fil:Calvo, J.C. Universidad de Buenos Aires. Facultad de Ciencias Exactas y Naturales; Argentina. Fil:Barañao, J.L.S. Universidad de Buenos Aires. Facultad de Ciencias Exactas y Naturales; Argentina. Fil:Charreau, E.H. Universidad de Buenos Aires. Facultad de Ciencias Exactas y Naturales; Argentina. JOUR info:eu-repo/semantics/openAccess http://creativecommons.org/licenses/by/2.5/ar http://hdl.handle.net/20.500.12110/paper_0012186X_v18_n5_p385_Tesone
institution Universidad de Buenos Aires
institution_str I-28
repository_str R-134
collection Biblioteca Digital - Facultad de Ciencias Exactas y Naturales (UBA)
topic Androgen receptors
cytosol binding sites
R1881
rat prostate
streptozotocin-diabetes
androgen receptor
androstanolone
androstanolone h 3
drug receptor
insulin
methyltrienolone h 3
metribolone
radioisotope
streptozocin
testosterone
unclassified drug
animal experiment
article
diabetes mellitus
endocrine system
male genital system
prostate
rat
Animals
Body Weight
Cytosol
Diabetes Mellitus, Experimental
Epididymis
Estrenes
Insulin, Long-Acting
Male
Metribolone
Organ Size
Prostate
Rats
Receptors, Androgen
Receptors, Steroid
Testis
Testosterone
Testosterone Congeners
spellingShingle Androgen receptors
cytosol binding sites
R1881
rat prostate
streptozotocin-diabetes
androgen receptor
androstanolone
androstanolone h 3
drug receptor
insulin
methyltrienolone h 3
metribolone
radioisotope
streptozocin
testosterone
unclassified drug
animal experiment
article
diabetes mellitus
endocrine system
male genital system
prostate
rat
Animals
Body Weight
Cytosol
Diabetes Mellitus, Experimental
Epididymis
Estrenes
Insulin, Long-Acting
Male
Metribolone
Organ Size
Prostate
Rats
Receptors, Androgen
Receptors, Steroid
Testis
Testosterone
Testosterone Congeners
Tesone, M.
Oliveira-Filho, R.M.
Biella de Souza Valle, L.
Calvo, J.C.
Barañao, J.L.S.
Foglia, V.G.
Charreau, E.H.
Androgen receptors in the diabetic rat
topic_facet Androgen receptors
cytosol binding sites
R1881
rat prostate
streptozotocin-diabetes
androgen receptor
androstanolone
androstanolone h 3
drug receptor
insulin
methyltrienolone h 3
metribolone
radioisotope
streptozocin
testosterone
unclassified drug
animal experiment
article
diabetes mellitus
endocrine system
male genital system
prostate
rat
Animals
Body Weight
Cytosol
Diabetes Mellitus, Experimental
Epididymis
Estrenes
Insulin, Long-Acting
Male
Metribolone
Organ Size
Prostate
Rats
Receptors, Androgen
Receptors, Steroid
Testis
Testosterone
Testosterone Congeners
description Male rats rendered diabetic by IV streptozotocin (65mg/kg body weight) were treated with exogenous insulin or testosterone. Charcoal-coated dextran and polyacrylemide gel electrophoresis techniques were employed in studying the characteristics of androgen (R1881) binding to prostate cytosol protein. In comparison with normal (N) rats, the replacement therapy of diabetic (D) animals with insulin (D+I) or testosterone (D+T) was able to restore epididymal weight (N = 0.40 ±0.04 g; D = 0.18 ± 0.02 g; D+I = 0.42 ± 0.05 g; D+T = 0.40 ± 0.06 g) and total prostate weight (N = 0.24 ± 0.02 g; D = 0.15 ± 0.02 g; D+I = 0.24 ± 0.05 g; D+T = 0.35 ± 0.06 g). Testicular endogenous content of testosterone was restored after insulin treatment (N = 154 ± 13 ng/testis; D = 41 ± 5 ng/testis; D+I = 142 ± 9 ng/testis), and significant improvements of serum testosterone levels were also achieved (N = 540 ± 64 ng/100 ml; D = 238 ± 37 ng/100 ml; D+I = 358 ± 18 ng/100 ml). Prostate cytosol of streptozotocin-diabetic rats had strongly lowered capacity for 3H-R1881 binding compared with controls (94 and 12 fmol/mg protein, respectively). Testosterone treatment produced a 3.3-fold improvement of this lowered value, whereas the increment seen with insulin was less (1.5-fold). It is emphasized that some of the improvements caused by insulin replacement therapy in diabetic animals are due to the partial restoration of testosterone secretion. Thus, the combined actions of insulin and testosterone (instead of insulin alone) seem to be of major importance in the maintenance and regulation of accessory sex glands function. © 1980 Springer-Verlag.
format JOUR
author Tesone, M.
Oliveira-Filho, R.M.
Biella de Souza Valle, L.
Calvo, J.C.
Barañao, J.L.S.
Foglia, V.G.
Charreau, E.H.
author_facet Tesone, M.
Oliveira-Filho, R.M.
Biella de Souza Valle, L.
Calvo, J.C.
Barañao, J.L.S.
Foglia, V.G.
Charreau, E.H.
author_sort Tesone, M.
title Androgen receptors in the diabetic rat
title_short Androgen receptors in the diabetic rat
title_full Androgen receptors in the diabetic rat
title_fullStr Androgen receptors in the diabetic rat
title_full_unstemmed Androgen receptors in the diabetic rat
title_sort androgen receptors in the diabetic rat
url http://hdl.handle.net/20.500.12110/paper_0012186X_v18_n5_p385_Tesone
work_keys_str_mv AT tesonem androgenreceptorsinthediabeticrat
AT oliveirafilhorm androgenreceptorsinthediabeticrat
AT bielladesouzavallel androgenreceptorsinthediabeticrat
AT calvojc androgenreceptorsinthediabeticrat
AT baranaojls androgenreceptorsinthediabeticrat
AT fogliavg androgenreceptorsinthediabeticrat
AT charreaueh androgenreceptorsinthediabeticrat
_version_ 1807315058891423744